GB Sciences, Inc. (GBLX)
OTCMKTS · Delayed Price · Currency is USD
0.0005
+0.0002 (66.67%)
Jan 21, 2026, 9:30 AM EST
GB Sciences Market Cap
GB Sciences has a market cap or net worth of $256.2 thousand as of January 23, 2026. Its market cap has decreased by -87.41% in one year.
Market Cap
256.20K
Enterprise Value
2.25M
Revenue
97.24K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since March 19, 2014, GB Sciences's market cap has decreased from 2.53M to 256.20K, a decrease of -89.89%. That is a compound annual growth rate of -17.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 256.20K | - |
| Dec 31, 2025 | 256.20K | -84.27% |
| Dec 31, 2024 | 1.63M | -36.83% |
| Dec 29, 2023 | 2.58M | -61.28% |
| Dec 30, 2022 | 6.66M | 2.29% |
| Dec 31, 2021 | 6.51M | -44.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Regenerative Medical Technology Group | 515.05K |
| Bio-Path Holdings | 502.77K |
| Helix BioMedix | 449.42K |
| Actavia Life Sciences | 385.91K |
| CNBX Pharmaceuticals | 348.31K |
| Oncology Pharma | 334.65K |
| Hemagen Diagnostics | 312.33K |
| Ampio Pharmaceuticals | 289.69K |